Imperial College London

Professor Sarah Fidler BSc. MBBS. FRCP. PhD

Faculty of MedicineDepartment of Infectious Disease

Professor of HIV and Communicable Diseases



+44 (0)20 7594 6230s.fidler




clinical trial centre Winston Churchill wingMedical SchoolSt Mary's Campus





Professor Sarah Fidler is a clinical academic who provides care for people living with HIV. Her main research interest is in the diagnosis, treatment and cure of HIV infection. 



Cook L, O'dell G, Vourvou E, et al., 2022, Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies, Nature Communications, Vol:13, ISSN:2041-1723, Pages:1-6

Abdool Karim Q, Archary D, Barré-Sinoussi F, et al., 2022, Women for science & science for women: gaps, challenges and opportunities towards optimizing HIV-1 prevention, Frontiers in Immunology, ISSN:1664-3224

Fogel JM, Zewdie K, Clarke WA, et al., 2022, Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)., Open Forum Infect Dis, Vol:9, ISSN:2328-8957

Probert WJM, Sauter R, Pickles M, et al., 2022, Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study, The Lancet Hiv, Vol:9, ISSN:2352-3018, Pages:e771-e780

Macleod D, Shanaube K, Skalland T, et al., 2022, Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis., Lancet Hiv, Vol:9, Pages:e751-e759

More Publications